The programmed death receptor-ligand 1 (PD-L1) is abundantly expressed on the cell membrane of tumor cells, and its interaction with PD-1 leads to lymphocyte death, suppression of T-cell activation, and reduction in cytokines production, ultimately enabling tumor cells to evade immune (9). This evidence concerns the gene CD274 and neoplasm.